vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2018-4-134-141vtio-960Research ArticleПо материалам IX Всероссийского съезда трансплантологовAccording to the Materials of the IX All-Russian Congress of TransplantИмплантируемые устройства: мост к трансплантации сердцаImplantable devices: a bridge to heart transplantationЦимпферД.ZimpferD.ВидеманнД.WiedemannD.

Waehringer Guertel 18-20, 1090 Vienna

Waehringer Guertel 18-20, 1090 Vienna

НисснерА.NeissnerA.Медицинский университет ВеныАвстрияMedical University of ViennaAustria201831012019204134141Copyright © Цимпфер Д., Видеманн Д., Нисснер А., 20192019Цимпфер Д., Видеманн Д., Нисснер А.Zimpfer D., Wiedemann D., Neissner A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/960

Терминальная стадия сердечной недостаточности представляет существенную проблему для системы здравоохранения во всем мире. Несмотря на значительные усовершенствования (медикаментозное лечение сердечной недостаточности, имплантируемые кардиовертеры, устройства ресинхронизации), длительная выживаемость и качество жизни таких больных остаются неудовлетворительными. Трансплантация сердца является эффективным методом лечения терминальной сердечной недостаточности, однако ее применение ограничено увеличивающимся дефицитом доступных донорских органов одновременно с жесткими критериями отбора реципиентов.

Terminal stage heart failure represents a substantial worldwide problem for the healthcare system. Despite significant improvements (medical heart failure treatment, implantable cardioverters, cardiac resynchronization devices), long-term survival and quality of life of these patients remain poor. Heart transplantation has been an effective therapy for terminal heart failure, but it remains limited by an increasing shortage of available donor organs along with strict criteria defining acceptable recipients.

трансплантация сердцаустройство левожелудочкового обходамост к трансплантацииheart transplantationLVADbridge to transplantationReferencesMilano CA, Simeone AA. Mechanical circulatory support: devices, outcomes and complications. Heart Fail Rev. 2013; 18: 35–53.Milano CA, Simeone AA. Mechanical circulatory support: devices, outcomes and complications. Heart Fail Rev. 2013; 18: 35–53.Pierce WS, Parr GV, Myers JL et al. Ventricular-assist pumping patients with cardiogenic shock after cardiac operations. N Engl J Med. 1981; 305: 1606–1610.Pierce WS, Parr GV, Myers JL et al. Ventricular-assist pumping patients with cardiogenic shock after cardiac operations. N Engl J Med. 1981; 305: 1606–1610.Lund H, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report – 2015; Focus Theme: early graft failure. J Heart Lung Transplant. 2015; 34: 1244–1254.Lund H, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report – 2015; Focus Theme: early graft failure. J Heart Lung Transplant. 2015; 34: 1244–1254.Portner PM, Oyer PE, McGregor CG et al. First human use of an electrically powered implantable ventricular assist system. Artif Organs. 1985; 936–941.Portner PM, Oyer PE, McGregor CG et al. First human use of an electrically powered implantable ventricular assist system. Artif Organs. 1985; 936–941.Prinzing A, Herold U, Berkefeld A, Krane M, Lange R, Voss B. Left ventricular assist devices – current state and perspectives. J Thorac Dis. 2016; 8 (8): E660–E666.Prinzing A, Herold U, Berkefeld A, Krane M, Lange R, Voss B. Left ventricular assist devices – current state and perspectives. J Thorac Dis. 2016; 8 (8): E660–E666.Kirklin JJ, Pagani F, Kormos R et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017; 36: 1080–1086.Kirklin JJ, Pagani F, Kormos R et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017; 36: 1080–1086.Levin AP, Uriel N, Takayama H et al. Device exchange in HeartMate II recipients: long-term outcomes and risk of thrombosis recurrence. ASAIO. 2015; 61: 144–149.Levin AP, Uriel N, Takayama H et al. Device exchange in HeartMate II recipients: long-term outcomes and risk of thrombosis recurrence. ASAIO. 2015; 61: 144–149.Haberl T, Riebandt J, Mahr S et al. Viennese approach to minimize the invasiveness of ventricular assist device implantation. Eur J Cardiothorac Surg. 2014; 46: 991– 996.Haberl T, Riebandt J, Mahr S et al. Viennese approach to minimize the invasiveness of ventricular assist device implantation. Eur J Cardiothorac Surg. 2014; 46: 991– 996.Riebandt J, Haberl T, Mahr S et al. Off-Pump HeartWare ventricular assist device implantation with outflow graft anastomosis to the left subclavian artery. Ann Thorac Surg. 2013; 97: 2214–2216.Riebandt J, Haberl T, Mahr S et al. Off-Pump HeartWare ventricular assist device implantation with outflow graft anastomosis to the left subclavian artery. Ann Thorac Surg. 2013; 97: 2214–2216.Zimpfer D, Netuka I, Schmitto JD et al. Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes. Eur J Cardiothorac Surg. 2016; 50: 548–554.Zimpfer D, Netuka I, Schmitto JD et al. Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes. Eur J Cardiothorac Surg. 2016; 50: 548–554.Mehra MR, Naka Y, Uriel N et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017; 376: 440–450.Mehra MR, Naka Y, Uriel N et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017; 376: 440–450.McGee E Jr, Chorpenning K, Brown MC et al. In vivo evaluation of the HeartWare MVAD Pump. J Heart Lung Transplant. 2014; 33: 366–371.McGee E Jr, Chorpenning K, Brown MC et al. In vivo evaluation of the HeartWare MVAD Pump. J Heart Lung Transplant. 2014; 33: 366–371.Tamez D, LaRose JA, Shambaugh C et al. Early feasibility testing and engineering development of the transapical approach for the HeartWare MVAD ventricular assist system. ASAIO J. 2014; 60: 170–177.Tamez D, LaRose JA, Shambaugh C et al. Early feasibility testing and engineering development of the transapical approach for the HeartWare MVAD ventricular assist system. ASAIO J. 2014; 60: 170–177.Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg. 2007; 133 (3): 689– 695.Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg. 2007; 133 (3): 689– 695.

The authors declare that there are no conflicts of interest present.